NIH-funded research R01 grant

Understanding how a protein affects allergic reactions in mast cells

Official title: NHERF1 regulates MRGPRX2/MrgprB2 responses in mast cells

Funded at Michigan State University · NIH-10711042 · Data updated 2026-11-12

This study is looking at how a protein called NHERF1 affects mast cells, which play a big role in allergic reactions, to better understand how they respond in conditions like asthma and hives, with the hope of finding new treatments for these allergies.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startJuly 12, 2023
Project endJune 30, 2029
Funding year2023
Award (this year)$460,688
NIH project number1R01AI177305-01
Project IDNIH-10711042 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with allergic diseases such as asthma, hives, or those experiencing pseudoallergic reactions.

Less likely to help

Patients without allergic conditions or those not affected by mast cell-related disorders may not benefit from this research.

What this research studies

This research investigates the role of a specific protein, NHERF1, in regulating responses of mast cells, which are crucial for allergic reactions. The study focuses on a receptor known as MRGPRX2, which is linked to pseudoallergic reactions and chronic inflammation in conditions like asthma and hives. By using advanced mouse models and human-derived mast cells, the research aims to uncover the molecular mechanisms behind these responses, potentially leading to new therapeutic strategies for allergic diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from allergic reactions and related conditions.

How similar studies have gone: Previous research has shown promising results in understanding mast cell functions and their role in allergic responses, indicating that this approach has potential for success.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Laumet, Geoffroy O — Michigan State University
  • Study coordinator: Laumet, Geoffroy O

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.